Literature DB >> 15639739

Sabotage and exploitation in macrophages parasitized by intracellular protozoans.

Eric Y Denkers1, Barbara A Butcher.   

Abstract

Macrophages are crucial in immunity to infection. They possess potent antimicrobial function, and efficiently process and present peptide antigens for T-cell activation. Despite this, the intracellular protozoan parasites Toxoplasma gondii, Trypanosoma cruzi and Leishmania spp. target macrophages for infection. Each has adopted unique strategies to subvert macrophage antimicrobial functions. The parasites sabotage killing activities through sophisticated manipulation of intracellular macrophage signaling pathways. These subversive activities are probably dictated by the need to evade microbicidal effector function, as well as to avoid proinflammatory pathology that can destabilize the host-parasite interaction. The molecular details of how intracellular protozoans manipulate macrophage signal transduction pathways for their own ends are beginning to emerge.

Entities:  

Mesh:

Year:  2005        PMID: 15639739     DOI: 10.1016/j.pt.2004.10.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  27 in total

1.  A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages.

Authors:  Dana G Mordue; Casey F Scott-Weathers; Crystal M Tobin; Laura J Knoll
Journal:  Mol Microbiol       Date:  2006-12-11       Impact factor: 3.501

2.  The role of P2 receptors in controlling infections by intracellular pathogens.

Authors:  Robson Coutinho-Silva; Cristiane Monteiro da Cruz; Pedro M Persechini; David M Ojcius
Journal:  Purinergic Signal       Date:  2007-01-12       Impact factor: 3.765

3.  A transmembrane domain-containing surface protein from Toxoplasma gondii augments replication in activated immune cells and establishment of a chronic infection.

Authors:  Angela M Pollard; Sini Skariah; Dana G Mordue; Laura J Knoll
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

Review 4.  Kinetoplastids: related protozoan pathogens, different diseases.

Authors:  Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.

Authors:  Florence Dzierszinski; Marion Pepper; Jason S Stumhofer; David F LaRosa; Emma H Wilson; Laurence A Turka; Sandra K Halonen; Christopher A Hunter; David S Roos
Journal:  Infect Immun       Date:  2007-09-10       Impact factor: 3.441

Review 6.  The function of Fcγ receptors in dendritic cells and macrophages.

Authors:  Martin Guilliams; Pierre Bruhns; Yvan Saeys; Hamida Hammad; Bart N Lambrecht
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

7.  Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages.

Authors:  Smita Misra; Manish K Tripathi; Gautam Chaudhuri
Journal:  J Biol Chem       Date:  2005-06-14       Impact factor: 5.157

8.  Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro.

Authors:  Daniel J Loegering; James R Drake; Jeffrey A Banas; Tamara L McNealy; Debbie G Mc Arthur; Laura M Webster; Michelle R Lennartz
Journal:  Microb Pathog       Date:  2006-09-25       Impact factor: 3.738

9.  PTR1-dependent synthesis of tetrahydrobiopterin contributes to oxidant susceptibility in the trypanosomatid protozoan parasite Leishmania major.

Authors:  Bakela Nare; Levi A Garraway; Tim J Vickers; Stephen M Beverley
Journal:  Curr Genet       Date:  2009-04-25       Impact factor: 3.886

10.  Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Authors:  Guadalupe Andreani; Ana M Celentano; María E Solana; Silvia I Cazorla; Emilio L Malchiodi; Liliana A Martínez Peralta; Guillermina L Dolcini
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.